News

Jan Holmgren receives global health award

23 November 2018 | 9:14 am
Jan Holmgren Foto Malin Arnesson
Professor Jan Holmgren at the University of Gothenburg is one of this year’s recipients of Prince Mahidol’s Award in Public Health. Prince Mahidol’s Award in Public Health is being awarded to Jan Holmgren and John Clemens for their ground-breaking research on “the development, evaluation and introduction of effective vaccines for combating cholera.” Holmgren is receiving […]
News

Moberg Pharma granted patent in China

23 November 2018 | 8:56 am
peter-volpert
The company’s MOB-015 has been granted patent protection in China, valid until 2032. MOB-015 is an internally developed topical formulation of terbinafine for the treatment of onychomycosis, currently under clinical development in phase 3. MOB-015’s patent protection thus covers the key markets for commercialization. Moberg Pharma has previously been granted patent protection for MOB-015 in […]
News

Health technology: From startup to market

21 November 2018 | 9:55 am
Kaare Smith - 2014 Blue Dot
What challenges and resources do health tech entrepreneurs need to know about? The Nordic region is good at supporting drug and device development. But how do health technology ideas such as apps and algorithms for patient tracking and virtual doctor visits get to market? Advice User input, teamwork, and local resources led the Norwegian company […]
News

Dignitana launches clinical trial in China

21 November 2018 | 8:45 am
dignitana_caps
The company is partnering with Beijing University Cancer Hospital and Konica Minolta in a clinical trial to assess the efficacy of scalp cooling for chemotherapy-induced hair loss in women with breast cancer. Dr. Tao Ouyang, Chairman of Breast Center of Beijing University Cancer Hospital will lead the study which includes 256 patients at Beijing University Cancer Hospital over […]
News

AlgoDx develops evidence-based AI diagnostics

21 November 2018 | 8:35 am
sepsis
The Swedish health tech startup plans to use evidence-based methods and clinical research strategies to develop AI algorithms for healthcare. The company is associated to Uppsala University and plans to initiate the first clinical studies in 2019. AlgoDx’s most advanced development project involves an algorithm for prediction of the risk of sepsis. “Algorithms can play an […]
News

New inflammation inhibitor discovered

21 November 2018 | 8:22 am
Thomas Helleday
A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action. By inhibiting a certain protein, the researchers were able to reduce the signals that trigger an inflammation. “We’ve developed a new drug molecule that inhibits inflammation,” says Professor Thomas Helleday, at the […]
News

LIDDS speeds up enrollment in phase IIb study

21 November 2018 | 8:12 am
Monica Wallter
LIDDS adds two major university clinics in Lithuania to its ongoing Phase IIb study, the National Cancer Institute in Vilnius and the University Clinic of Kaunas. The two clinics are now ready to start inclusion of patients in Part II of the LPC-004 study. Lithuanian authorities have recently approved the study protocol and the Liproca […]
News

Immunicum enters collaboration with big pharma

19 November 2018 | 10:43 am
Carlos de Sousa
The company will collaborate with Merck and Pfizer to evaluate ilixadencel, an off-the-shelf cell-based cancer immune primer, in combination with avelumab, a human anti-PD-L1 monoclonal antibody, in a planned multi-indication Phase Ib/II clinical trial. Immunicum will initiate a study of ilixadencel in the fourth quarter of 2018. Following completion of the Ib portion of the study, […]
News

Positive results from Bonesupport

19 November 2018 | 10:22 am
bonesupport-cerament-g
The company has announced new data from the CERTiFy (CERAMENT Treatment of Tibia Plateau Fracture defects) study comparing CERAMENT|BVF with autologous iliac bone graft (autograft). “Successfully completing the ground-breaking CERTiFy study, to demonstrate CERAMENT BVF is non-inferior to autograft in treating tibia plateau fracture defects, is a major milestone for BONESUPPORT. We expect the results from the study […]
News

Medicon Valley: Cross-border strengths

16 November 2018 | 12:21 pm
ESS
Despite a current slowdown in growth rate, Medicon Valley still ranks high among Europe’s life science clusters. Right now, the region is going through an interesting transition period to remain the key gateway to Nordic life science. “The life science industry in the region has links back to the agricultural industry and breweries, such as […]